Compendium on Continuing Education for the Practicing Veterinarian 1998: Vol 20 Index

7 Pages·1998·1.7 MB·English

The Compendium December 1998
CUMULATIVE YEAR-END INDEX—1998
SMALL ANIMAL AUTHOR INDEX
\ a
Addie, DP.,e riPtroneivteinst ing( JulyF elsiunep plIenmfeecntti)ou s Hedrich, PerHit.o Jn.i.t iPs r(Jeulyv esunpFpetllieinmee nnItng fe ct COissttroorw s‘h
a Hellver, P.W., 140 Otte. C. M
Hendrix, C. M., 1099 1299, 1342
Henry, C. J., 728, 823
Barr, M. C., Preventing Feline Infectious Herrewegh. A. A. P. M., Preventing Feline
Peritonitis (July supplement) Infectious Peritonitis (July supplement)
Behrend, E. \., 673, 679 Herron, VM. R., 1234
Benefield, I . 1099, 1259, 1342 Hess, B.S. 701
tiller, D.S.. Hnilica, K. A. 298
bird, K. A. 1 Holznagel, E., Preventing Feline Infectiou
Blagburn, B. L., 415 Peritonitis (July supplement) supplemet
Bloom, B. C., 1099, 1239, 1342 Horzinek, M. C., Preventing Feline A. M., Pre
Bolla, S., Preventing Feline Infectious Infectious Peritonitis (July Peritor J
Peritonitis (July supplement) supplement
joothe, D. ML. 15 Hoskins, J. D., Preventing Feline Infectious
Boothe, Jr.. H.W Peritonitis (July supplement)
Brooks, D. | 45 Hoskinson, J. J., 1225
Buss, VI. S., 728 Rafle, Vi
a
Jerram, f
Cepica, A., Preventing Feline Infectious Johnson
Peritonitis (July supplement) Johnston
Coates, J. R., 1025 Jones, B
Coleman, E. S., 1089
Conklin, S., | accine Technology in the 21st
orapi, CWe.n tu\.r, y Pr(eAvuegnutsitn g suFpeplilneem eI nfnet)c tious Kelch, W. J. 921
Peritonitis (July supplement) Kemppainen, R
Cote, E., 605, 791 Kirby, R., 27
Kitchell, B. E., 1011, 1109
Koehler, L. A.. 178
Komaromy, A. Vi. 343, 395
Davidson, E. B., 811,974 Araft, S. L., 1225
Kyles, A. I
DeBoer, D. J., 909
de Groot, R. J., Preventing Feline Infectious if supplement
Peritonitis (July supplement) ine Infectiou
Dewey, C. W., 47, 892, 1025
Dhaliwal, R.S., 1011, 1109 Larocea, R
Dhupa, \., 897, 993 LLéeehveeinllbéa, ueRr
Drobatz, K. J., 971
Lewhart, G 1998 TNAIC Antimicrobia
Therapy E-votics Proc (March
supplement)
Lewis, D. T., 65, 271 1121
Egberink,H . F., Preventing Feline Lindsay, D.S
Infectious Peritonitis (July Lobetti
supplement) Lomax Preventing Feline Infectio
Egger, E. L., 487 Peritonitis (July supplement)
'Eure ll, J. A. C., 487 LLoostohnrsokpy , ir.J..C . VM... D..4 87 7 Ut lTraaapvbpio,o a da1
Lailich, J. P., 178
Lantz, H.. Preventing Feline Infectious
Feldman, B. F., 1039 Peritonitis (July supplement) Thomas, f
Fehr, D., Preventing Feline Infectious Lynn, KR. C., 921 Thumchai, R
Peritonitis (July supplement) Tobias, kh. M
Flammer, K., 7998 TNAIC Antimicrobial
Therapy Exotics Proc (March
supplement) Mader, D. R.. 1998 T\AI Inftunicrobia
Foley, J. E., Preventing Feline Infectious Therapy Exotics Proc (March
Peritonitis (July supplement) supplement)
Ford, R. B., | accine Technology in the 21st Mahler, VM... Preventing Feline Infectious
Century (August supplement) Peritonitis (July supplement)
Foster, A. P., 909 Mama, k., 125
Friberg, C. A., 1121 Marks, S. L., 317 an hampen, kh. R.. | aecine Technolog
i MMaofrirde,t ta,Vi ... Ss. 43M5 1011, 1109 Vennema,th e H.J. isPtre ventiCenngtu r Feugluistn es uppInlfeectnioe is
Montgomery, R., 781 Perito ¢ (July supplement
Gaynor, J.S., 140 Morton, R. J., 442
Geiger, T. L., 1308 Muir, W. W., 78, 473, 349. Guide
Gillette, BR. L.. 1155 Carrving Fluids Decembe Waddell
Goggin, J. M.. 1225 supplement) Wail, RK. side te ryvgen-Carryvi
Groves, VM. G., 1308 Mullen, CeD.n, tur| ya cci(nAeu guTsetc hnsoulpopglye mei n Ward, ¢ } is ( } r supplement
Myer. C. W., 1199 Ware, VW 167
Wevrauch, B.A
White, S. D., 261
Haagmans, B. L.. Preventing Feline Whitley, R
Infectious Peritonitis (July Willard, M
supplement)
Williams
Hansen, B., Guide to Orvgen-Carryving Wohl, JS
Fluids (December supplement)
Wolf, A Tel li “un tious
Hauser, B., Preventing Feline Infectious
Peritonitis (July supplement) Olsen, C. W., Preventing Feline Infectious
Peritonitis (July supplement) Woods
The Compendium December 1998
VOLUME 20 SMALL ANIMAL PAGINATION
Issue Pages Issue Pages
January 1-89 July 761-841
February 1135-219 August 881-941
March 241-369 September 961-1055
April 401-505 October 1073-1147
May 529-625 November 1177-1261
June 665-735 December 1297-1349
SMALL ANIMAL SUBJECT INDEX
Addison's disease, 921 935 Bartonella infections, 1508-1317 dopamine agonists and monoamine
causes, 922 cat flea, 1311 oxidase inhibitors, 692-694
diagnosis, 926-930 diagnostic techniques, 1312-1315 hypothalamic—pituitary—adrenal axis,
history, 921-922 epidemiology and pathogenesis of cat 679-680
incidence and prevalence, 922-926 scratch disease, 1309-1310 inhibitors of steroid synthesis, 691 692
pathophysiology, 926 experimental models, feline, 1311 mitotane, 680-691
treatment, 990-933 in cats, 13510-1311
Advances in (see Allergy: Critical care; in dogs, 1311-1312
Feline medicine; Hypothyroidism: in humans, 1310
Neurology: Parasitology) prevention, 1314-1315 Dental radiography (see Radiography)
Allergy specific organisms, 1508 Dermatology
diagnosis and treatment, advances in, treatment, 1314 dermatoses, canine life-threatening,
258-259 Biliary obstruction, 12235-1244, 1260 271-283, 351
food allergy, canine, 261 269 clinical presentation, 1227 autoimmune disorders, 271-274
causes, 261 diagnostic imaging, 1227-1233 cutaneous drug reactions, 274 78
diagnostics, 263-268 differential diagnoses, 1226-12 cutaneous vasculitis, 280
history and clinical signs, 262-263 normal anatomy and physiology, 1225 generalized demodicosis, 278
signalment, 261-262 pathophysiology, 1226 neoplasia, 279-280
insect hypersensitivity, 1121 1151, tite wounds (see Wounds) superficial necrolytic dermatitis,
1145 srain injury, severe, 897-905, 993-1006 278-279
antigen source, 1121 barbiturates, 1000 endocrine disease, canine, cutaneous
clinical signs, 1123-1126 corticosteroids, 998-999 manifestations (see Endocrine
diagnosis, 1126-1128 extracranial causes, 900-902 dise ase)
treatment, 1128-1130 fluid therapy, 994-998 food allergy (see Allergy)
Anesthesiology hyperventilation, 999-1000 insect hypersensitivity (see Allergy)
cardiovascular disease, 78-87, 173-484 hypothermia, 1000-1002 ivermectin, 193-200, 459-469, 484
anesthetic protocols, 479 intracranial causes, 898-900 canine ectoparasitism, 459-463
applied physiologic principles, 81-82 oxygen therapy, 999 feline ectoparasitism, 463-468
arterial blood oxygen-carrving physiologic monitoring, 1002-1005 other uses, 468
capacity, 84-85 Brucellosis infection, canine pharmacology, 193-195
cardiac output, 82-86 (Compendium Challenge), 620-625 toxicology, 195-198
drugs, 86, 473-479 i pyoderma (see German shepherd
history, 78-79 pyoderma)
monitoring, 479-480 Diabetes mellitus (see Cushing's
physical examination and risk alcium oxalate urolith recurrence, syndrome )
assessment, 79-81 management of canine, 178-189 Diaphragmatic hernia, imaging modalities
treatment of common anine hip dysplasia (see Hip dysplasia) to confirm, 1199-1210
_ emergencies, 480-483 ardiovascular disease (see additional imaging procedures,
eline anesthesia, new drugs in, Anesthesiology) 1201-1202
125-159 at scratch disease (see Bartonella survey films, 11599-1201
inhalant, 137 infections) techniques of historical interest,
injectable, 125-137 ervical spinal hyperesthesia, 1025-1037 1203-1206
Antimicrobial therapy, 1/998 TNAI€ clinical presentation, 1027 ultrasonography, 1206-1207
intimicrobial Therapy Exotics Proc diagnostic testing, 1028
(March supplement) neurologic examination and lesion
bacterial infections and antibiotic localization, 1027-1028
therapy in small mammals, /13-/22 treatment, 1028-1030 Electroretinography, 343 v51, 355-366,
common bacterial disease and hemotherapy (see Recombinant human 399
antibiotic therapy in reptiles, granulocyte colony-stimulating indications, 363-364
1223-133 factor) interpretation, 363
common bacterial infections and olloids, 27 +3 normal flash electroretinogram, 359
antibiotic use in companion birds, administration and monitoring, 28 quality, 359-363
134-148 clinical cases, 34-42 retina, 343-349
koi medicine and management, /5-/12 colloid oncotic pressure, 33 technique, 355-359
patient needs, 28 Emergency medicine (see Critical care
ompeadium Challenge (see Brucellosis monitoring: Shock)
Parasitosis) Endocrine disease (see also Addison's
Babesiosis, canine, 418-431 orticosteroids (see Shock) disease; Cushing's syndrome),
causative agent, 418 ritical care monitoring, advances in, canine, culaneous
clinical manifestations, 420 $23 43-145 manifestations, 287 ws
diagnosis, 426 ushing’s syndrome, canine, 679-702 acromegaly, 298
epidemiology, 418-419 concurrent diabetes mellitus, 701 717 dermatohistopathology, WO0-302
pathogenesis, 419-420 diabetes mellitus, 701-706 diabetes mellitus, 298
pathology, 423-426 diagnosis, 707-711 hyperadrenocorticism, 288-289
prevention, 428-429 insulin resistance, 706-707 hypopituitarism, 298
therapy, 426-428 treatment, 711-715 hyposomatotropism in mature dogs, 298
The Compendium December 1998
SMALL ANIMAL SUBJECT INDEX—CONTINUED
hypothyroidism, 288 a oncology, 728-735
recurrent flank alopecia, 300 treatment protocols
ssuepxe-rfhiocrimalo nen ecdroeirymtaitco sdeesr,m at2i8t9i-s,2 983 00 Myasthenia gravis, canine acquired, 47-59 veterinary guideline
associated conditions, 33
Endoesqcuoippym,e nt3,0 7-331103- 312 drugs that may hinder neuromuscular
transmission, 33-54
fmtiyunplaetnsic yieoafa; r s copcploeansns,,i de33r00a79t-i-3o30n1s80, 308-309 tphreorgaanpdoevsuaitnsic ce asn,od p t3ai4no ntsi,c ip4a7t-e5d3 treatment Shockh,y pov35o741l9-e-5m58i68c7,, 66c0o rticosteroids, in
Esophagitis and benign esophageal adverse effects, 383-584
strictures, 203-212 clinical and experimental studies
diagnosis, 204-205 a 5 .
pathogenesis, 203-204 Neurology and neurosurgery (see also treatment, 372
therapy, 205-210 Brain injury; Cervical spinal classification, 349-350
External skeletal fixation, 487-302 hyperesthesia; Tetanus and compensatory response
biological environment, 493-495 botulism), advances in, 892-895 management, 360-365
bone healing, 487-489 905 monitoring, 959
external fixators, 489-492 Neurotoxins, clostridial (see Tetanus and pathophysiology, 350-556
healing time, 497-498 botulism) types 559-560
mechanical environment, 492-493 Nutraceuticals, safety and efficacy, 15-21 Suture materials, 155-165, 201
radiography, 495-497 characteristics, 155-199
sources, 162
specific tissues, 159-162
Otitis externa and media, chronic canine,
Feline infectious peritonitis, Preventing 909-919, 941
Feline Infectious Peritonitis (July antibacterial agents, 910-913
supplement) clinical signs, 910 Tetanus and botulism, 1089-1097
Feline medicine, advances in, 1305, 1349 diagnostic and therapeutic botulinum toxin, 1093
Fentanyl, 721-726 considerations, 913-918 clinical signs, 1089-1091
Food allergy, canine (see Allergy) Pseudomonas aeruginosa, 909-910 diagnosis, 1091-1092
FFrraaccttuurreefs i,x haetsaicloainpn)u gl ar(,se e in Exdotgesr,n al1 25s4ke-l1e2t6al0 Over-thei7n-9 c1vo-eu8t0ne8tr,ei nra 8r2yh9 ummaedni cimneed,i ca6t0i3o-n6s1,7 , use tmprreeocaphthmayelnnaitx,si ms , 1o0f19 02a9-c3t1 i0o9n,3 1091
anatomy, 1254 analgesic, 792-794 Therapeutics in Practice (see Calcium
classification, 1254-1255 dermatologic, 801-804 oxalate urolith, Fentanyl
concurrent injuries, 1255-1256 gastrointestinal, 604-612 Nutraceuticals)
postoperative management and ophthalmic, 612-615 Travel, international, with pets, 1099-1107
complications, 1259 respiratory, 794-800 1239-1251, 1342-1348
signalment and diagnosis, 1256 urinary, 612 ategory | pathogens, 1240-1241
treatment, 1256-1259 Oxygen-carrying fluids, Guide to Orygen ategory Il pathogens, 1241-1249
Carrying Fluids (December ategory II pathogens, 1342-1345
supplement) ategory IV pathogens, 1343-1346
acute therapy of anesthetic ategory V pathogens, 1346
German shepherd pyoderma, 831-840 emergencies, /10-/13 L nited States
clinical signs, 832 monitoring the critical patient, /14—-/22 1102
diagnosis and treatment, 832-839 synthetic colloids and blood abroad, 1099-1100
history and signalment, 831-832 substitutes, /4—-/9 returning to the United States
pathophysiology, 831 1104-1105
a U.S. pathogen exportation, 1346
within Europe, 1102-1104
Pain, acute postsurgical, 140-153 rularemia, feline, 442-457
Hip dysplasia, canine 781-788, 829 Parasitology (see also Babesiosis; causative agent, 442-443
Holter monitoring, 167-177, 201 Parasitosis; Tularemia), advances clinical signs, 444
equipment, 167-168 in, 415-416 clinicopathologic features, 444
heart rate and rhythm variations, Parasitosis, delusions of (Compendium control, 454
173-176 Challenge), 433-439 diagnosis, 444-449
Holter report, 172-173 Platelet dysfunction, 1039-1053 gross pathology, 444
hook-up and removal, 168-172 clinical approach, 1041 hosts, 445
indications, 167 physiology, 1040-1041 pathogenesis, 4
Housbeeshoaivliionrg , hifsetloirnye,, 11331291--11333293 Porttohsrysotmebmoiccy tosphautnhtsy,, ex1t0r4a1h-e1p0a5t1i c, ppurbelviac lehnecael th, 454
differential diagnosis, 1320-1321 surgical approaches to, 393-601, transmission, 443-444
fecal marking, 1332 618 treatment, 449-454
treatment, 1323-1328, 1332-1337 anatomic considerations, 993-395 rumors, oral, 1011-1022, 1109-1119
urine marking, 1331-1332 dissection and occlusion, 995-601 clinical signs, 1014
How | Treat (see Hip dysplasia; Pain) Pseudomonas (see Otitis externa and diagnosing and staging, 1014-1016
Human medications (see Over-the media) pathology, 1011-1014
counter) Pythiosis, 63-75 prognostic factors, 1109-1110
Hyperadrenocorticism (see Addison's canine, 64-71 specific types, 1016-1019
disease; Cushing's syndrome) etiology and pathophysiology, 64 treatment, 1110-1115
Hypothyroidism, canine, advances in feline, 71-72 a
diagnostic testing, 673-674, 759 historical aspects, 63-64
Hypovolemic shock (see Shock)
Vaccination guidelines, feline, 936-941
Vaccines, | accine Technology in the 21st
Century (August supplement)
Imaging Di(aspeeh raBiglmiaartyi co bshterruncita;i on; Radiddoeignatrpaahlpr,h ayg3 m3a9t-i3c4 0 hernia, in, 1199-1201 iprmemvuenntei ves yshteeaml tha ncda rev,a cc/i2n5e-s/,2 7 /5-/18
InflammaRtaodriyo grbaopwheyl) disease, canine, isknetleertparle taftiixoatni,o n,1 2i1n5, -1428295- 492 rvaecccoimnbeisn aanntd tveacchcnionaltoigoyn,s , /19-/24
317-332 Recombinant human granulocyte colony
diagnosis, 318 stimulating factor, veterinary uses
dietary management, 318-322 infectious diseases, 823-829
future therapy, 328-329 effects of inflammation on Wounds
pathophysiology, 317-318 neutrophil counts, 825 bite, 811-821, 974-991, 1006
pharmacologic management, 322-328 feline immunodeficiency virus and antibiotic therapy, 984-990
prognosis, 329 feline leukemia virus, 825 bandages, 976-982
Intracranial disease (see Cervical spinal neutropenia, 824 classification, 812
hyperesthesia) parvoviral infection, 824 closure, 982-984
Ivermectin (see Dermatology) septicemia, 825 debridement, 975-976
The Compendium December 1998
SMALL ANIMAL SUBJECT INDEX—CONTINUED
drainage, 982 medicating and dressing, 1133-1145 polyethylene oxide occlusive
emergency treatment, 813-819 acemannan, 1133-1136 dressing, 1141
epidemiology, 811 bovine collagen, 1136 polyurethane foam, 1141
lavage, 974-975 calcium alginate, 1136-1140 tripeptide-copper complex,
microbiology, 812-813 hexamethylidisiloxane acrylate 1141-1142
pathophysiology, 812 copotymer, 1142-1145
special considerations, 990 maltodextrin nf, 1140-1141
EQUINE AUTHOR INDEX
a *
Andrews, F. M., 376, 628 Gaughan, E. M., 799, 944, 947, 1057 Paul, J. W., 309
ri Guy, J., 373 Pearson, FE. G., 1354
Baxter,G . M., 100 ki
BBeenadnleet,t , R.D . E.G,. ,8 461,0 0 1266 HHeaiwdkeiln,s ,J . RJ.. , I 155642 8 eaeie ao Oe
Bowman, J. M., 520 Henry, R. W., 628 ;
Braniecki, A., 517 Hubert, J. D., 846 ©
Buechner-Maxwell, \ , 222
Burks, B. S., Seahorn, T. L.. 1266
Byars, T. D., Siger, L., 628
aneps, A. J., 1060 Smith, B. L., 1060
pe | Southwood, L. L.. 100
Storts, R. W., 517
Carrick, J. B., 637
Chaffin, M. K.,
Cohen, N. D., 9 28, 1264 ‘ . J. D., 799, 947
Cornish, T. E., °,
van Harreveld, P. D., 739, 947
David, J. B., ~~
Divers. T. J.. 92. Martin, Jr., B. B., 1159
Mayhew, |. G., 744
ir § VMMciDcoCnannne,l l,M . SE.. , M6.3, 7 1159
MeFarlane, D., 373
Fenger, C. K., 1154 Murray.M . J.. 1352
VOLUME 20 EQUINE PAGINATION
Issue Pages Issue Pages
January 90-112 July 842-853
February 220-240 August 942-960
March 370-383 September 1056-1072
April 506-528 October 1148-1176
May 626-641 November 1262-1269
June 736-746 December 1350-1359
EQUINE SUBJECT INDEX
i 6|
treatment, 851
Angular limb deformities, 944-946, 955 Anticonvulsant therapy for mature Biopsy, colonic and rectal, 1354-1359, 1379
Anhidrosis, 846-8953 epileptic horses, 744-745 diagnosable conditions, 1356-1358
clinical signs, 846-847 Ascarid impaction, 100-106, 110 method, 1354-1315)5
deipaigdneomsiiosl,o g8y5,0 -885416 anthelmintic treatment, 105-106 normal mucosa, 1355-1356
diagnosis, 102 Biood—brain barrier function, 376-377, 383
histology of equine sweat glands, life evele, 100-101
847-S48 necropsy findings, 103 Pe |
physiology of sweating, 848 occurrence and risk factors, 101-102
potential mechanisms, 848-850 reasons for poor prognosis, 103-105 Cerebrospinal fMuid analysis, 376-377, 385
thermoregulation, 847 surgical treatment, 102-103 Chronic obstructive pulmonary disease,
The Compendium December 1998
EQUINE SUBJECT INDEX—CONTINUED
1266-1268 equine encephalomyelitis) clisingnsi ancd daiaglnosi s, 379-380
Colitis, acute, 92-99, 228-234, lsoerythrolysis, neonatal (see Kernicterus) control, 381
causes, 92 differential diagnosis, 380
clinical signs, 93-94 life cycles, 378-379
control, 231-232 ‘i pathophysiology, 380
diagnostic testing, 94-97 treatment, 380-381
epizootiology, 92-95 Kernicterus, 317-322 Penile surgery (see Surgery)
prevention, 232-233 human infant, 320-5322
signalment and history,9 5 neonatal isoeryvthrolysis, in a foal with isi
treatment, 228-231 317-520
Consultant's Corner (see Anticonvulsant Salmonella bacteria in fecal cultures,
therapy; Diclazuril; Salmonella; Pu | 1352-1353
Strangles) Strangles outbreak how to control
Lameness, dislitmb ain lfoa ls, 1060-1067 S44-845
io| angular deformities, 1065 Surgery
Nexural deformities, 1061-1065 penile, 947-954
Diclazuril, 1264-1265, 1269 fractures, 1063-1065 tlans penis, 947-952
ligament laxity, 1060-1061 penis and prepuce
Pe | Larval cyathostomosis, 309-315 urethral, 739-745, 745
clinical features, 310-511 female horses, 74
Eastern equine encephalomyelitiussi,n g life cycle, WO9-510 male horses, 739
diimamgunnosoep,e ro37x3i-d3a7s6e staining to treatment and control ii
Enteral feeding of sick newborn foals,
4 Tracheal stenosis and « ollapse, 628-656
Musculoskeletal and neurologic diseases anatomy, 628-629
1154-1157 effectso f, on breeding causes, 629-631
Equine Rounds (see Cerebrospinal fluid performance in stallions clinical signs, 631
analysis; Eastern equine 1159-1168 diagnosis, 632
encephalomyelitis; diagnostic approach, 1159-1161 treatment, 652-655
hernicterus) summary of cases, 1164-1166
i | therapeutic strategies, 1161-1164 ug
0 | L pdate on Equine Therapeutics (see
Hernias, inguinal, 1057-1059 Enteral feeding; Equine protozoal
llow | Treat (see Angular limb Omega-3 fatty acids, potential uses in myeloencephalitis; Omega-} fatty
deformities: Chronic obstructive equine diseases, 657-641 acids)
pulmonary disease; Hernias) rey Lrethral surgery (see Surgery)
Parasitic pneumonitis, 378-383, 400
Immunoperoxidase staining (see Eastern case examples, 381-382
FOOD ANIMAL AUTHOR INDEX
Lindsay, D. S., | eterinary Exchange
ai ie (November supplement)
Alvarez, F., 645 Kkdwards, S104 Mt |
Amass, S., S196 Elliott
Archbald, L., S280 Evre, P 5 Markel, Mi
Arthington, J. D.. 866 VicGrann
iri Medi, M., 82
Melancon ]
Field, R.. S104 Mobini, S. VL, S112
Bade. D. H.. S170 Forrest, | J. 856 Moreira, | S280, 1284
faker. W. D.. S138 Friendship, Rh. M Moser, D. W., 652
Barker, RK. D., 385
Barling, k., S104
Barr. B. C.. | eterinary Eeachange Garry, F.. 1275
(November supplement) Geishauser, 1
Braun, l., S270 Gemus, VM. |
Britt, J.. 645
jurke, J., S280 Gillespic
Greene, |
arpentet a 7 Herd, D. B.. 748
arstens. G Hernandez, J., 8215
henoweth, -. . 985 Herring, W. O., 876), S150 Painter, J., 645
hirase, \. K., 1572 Hilton, C.D. S112 Pugh, D. G., S112
orah, LR Pusterla, \., S270
ottrell, T
raig, T., S104
Johnson, E.G. S116
Querengiasser, K., S251
Lp | hains, | S205
de la Sota, RB. L., S280
DeLorenzo, VL, 1284 Revnolds, J. P.. | eterinary Exchange
Dewey, ( S82 (November supplement)
Drost, ML, S280 Larson. R. L.. S76, S130, 652 » Ric hardson, J W St 70 ;
Dubey, J. P.. | eterinary Exchange $259 Riseo, C. A... 38 », S280 1284
(November supplement) Lehenbauer, T. W.. 1362 Robert, B. S., 8170
Roussel, A. J., 1282
The Compendium December 1997
FOOD ANIMAL AUTHOR INDEX—CONTINUED
Rowland, W. K., S116
Thatcher, W. W., S280, 1284 Walstrom, D. J., S116
Trostle, S. S., 864, 856 Weekley, L. B., 833, 856
Wells, S. J., Veterinary Exchange
Schicker, E., S270 (November supplement)
Sears, G. L., 8138 Wikse, S. E., 8104, 748
Shearer, J. K., $158, S213 Wright, C. L., 866
Skogerboe, T. L., 8116 Veenhuizen, M. F., Si1
Smith, B. L., 385 Veit, H. P., 833, S56
Sprott, L. R., S170 Velez, J. S., 385
Zimmerman, G. L., 8116
VOLUME 20 FOOD ANIMAL PAGINATION
Issue Pages Issue Pages
January S1-S48 July 854-880
February S49-S96 August S145-S184
March 384-400 September S185-S240
April S97-S144 October S241-S288
May 642-664 November 1270-1296
June 747-760 December 1560-1592
FOOD ANIMAL SUBJECT INDEX
E
Anthelmintics, in feedlot cattle, S116—S123 Dairy Herd Investigation (see Milk National Johne’s Working Group (see
production) Johne's disease)
Dairy Nutrition Management (see Dry Natural service bulls, management and
dairy cows) economics of in dairy herds,
Dairy Production Management (see 385-390
Culling decisions; Natural service Nematodes, gastrointestinal, control
6-mannosidosis, $138—S140, S144 bulls) programs for sheep and goats,
Beef Nutrition Management (see Creep Dry dairy cows, nutritional management $112-S115, $123
feeding) of, 391-396 Neosporosis, Veterinary Exchange
Bovine pneumonic pasteurellosis, (November supplement)
533-846, S56-—S62
clinical presentation, 856-857
infective agents, 8S33-—S34 Estrus synchronization (see Replacement
pathophysiology, S58—S60 heifer development; Timed Osteochondrosis, bovine, 856-863, 875
prevention, S57-—S58 artificial insemination) clinical findings, 859-861
pulmonary immunology, S41-S42 pathophysiology, 856-857
respiratory system, S34—S40 predisposing factors, 857-859
stress, S40-S41 prognosis, 861-862
treatment, S58 Feedlot Nutrition Management (see treatment, 861
Bovine spongiform encephalopathy, Supplementation) OvSynch/TAI (see Timed artificial
S270-S27 Feedlot Production Management (see insemination)
clinical findings, S271-—S272, 8276 Anthelmintics)
examination, S272—S277
hiinstteorrpyr etaantdi ocnl inaincda l deiaxganmoisniast,i oSn2,7 7 S271 Papillomatous digital dermatitis,
$158-S166, S173, S213-—S223, S239
Breendeiunrgo,l ocgaitctl e,d isSt7u6r—bSa8n1c,e s, S1S3207—6S 133, Housing,S 20l5ow—-Sc2o0s9t and batch farrowing, housing, environment, and
S143-S144 management, S222
complementary breed strengths, recurrence, S220
S131-S132 residues, S221-—S222
crossbreeding systems, S132-—S133 resistance, S221
eohtexthpeeerrco tseainds,i mpa8rl1o 3g0eb-nrSye1 e3ddi1in fgf erteoonlcse,s ,S 8S07 6—S80 JohnmeNy'atsti hos1dn,2ia 8sl2e 1-a21sJ7e2o5,8h -3n1,e12 ’28s721 52 -W91o02r-81k32i,9n 1g 12G9r0o-u1p2,9 1 tttorrpeeiaacStta2mml1ee nn4ttt—r Se2aaf1tan7midle unrcteo ,n ttrSroi2la2l,1s , §S125187—-S—1S6252,0
vaccination, S221
Pathogen removal, effect of weaning age
on, S196—S203
CCoocwc/iCdaiolsfi s,H er8d1 24In—vSe1s2t9i gation (see 6 Lungworsmtosc,k ero uctablrveeask, 8i1n 0l4i—gSh1t0w9ei ght Porcine barcetsepriiraalt orpya thdoigseeansse, cSo1m1p-lSe2x1,
ictinobacillus pleuaropneumoniae,
mannosidosis; Lungworms)
Cow/Calf Nutrition Management (see S17-S20
Mineral nutrition) bacterial and viral agents, S11-—S12
Cow/Calf Production Management (see Mammary gland, bovine (see Mycoplasma hyopneumoniae, S12-S16
Profitable operations) Ultrasonography) Pasteurella multocida, S16—S17
Creep feeding in beef cattle production, Milk production during first lactation, Porcine reproductive and respiratory
748-756, 759 645-650 syndrome, S82-—S86, S95-—S96
Culling decisions in dairy cows, Mineral nutrition, influence on feedlot Profitable operations, in East Texas,
1362-1371 performance, 1372-1379 characterizing, 8170—S173
The Compendium December 1998
Pseudorabies, eradication in swine, S30-—S32 Index to Advertisers
Replacement heifer development (Continuing Education Series) Small Animal
anthelmintics, 8179
background, S225—S226 Abbott Laboratories
body condition score, S226 Feliway
breed, 653-655
conformation, 652-653
estrus synchronization, S260—S266 Biopure Corporation
expected progeny differences, 655-656 Oxyglobin
fat-soluble vitamins, 8177—S178
feed additives, S178—S179
growth implants, S179 Heska Corporation
macrominerals, 8174+—S176 Solo Step CH 1306—1307
net energy, S226—S227
phases of development, S227-s
protein, S227 Hill’s Pet Nutrition, Inc
puberty, S259-S260 Prescription Diet Canine r/d and w/d Formulas
ration formula, S227
selection criteria, 656-657 Luitpold Pharmaceuticals
trace minerals, S176—S177
water-soluble vitamins, 8178 Adequan Canine 1313, 1317
Ruminant Production Management (see Nematodes)
Nutramax Laboratories
Cosequin
Sarcoptic mange, swine, S87-—S95
Stockpeople, effect of on pigs, S22-S29, S48 Ralston Purina Co
Supplementation, vitamin E and trace-mineral, 866-874 CNM EN-Formula 1340-1341
Swine Production Management (see Coccidiosis; Housing;
Pathogen removal; Porcine reproductive and respiratory Corporate 1303
syndrome; Pseudorabies; Stockpeople)
Schering-Plough Animal Health
Orbax 1348, Cover 4
Teat canal injuries, covered, in dairy cows, 8251-—S257 ProTICall 1335
diagnosis, S252
incidence, S25) $252 Veterinary Learning Systems
prognosis, S2 )
treatment, 8253-8255 Readings in Companion Animal Behavior 1318
Timed artificial insemination, in dairy cattle, S280—S287, 1284-1290 vetshow.com Cover 3
associated management factors, S285—S286
calving interval, S280 Waltham
economic approaches, 1284-1288
estrus synchronization, S281 S/O Control pHormula
ovulation synchronization/TAl protocol, S281-S285
Equine
Ultrasonography, bovine mammary gland, S64—S74 Hoechst-Roussel Vet Co
anatomy, S67
equipment and techniques, 865-—S67 Regu-Mate
pathologic conditions of the mammary gland, S67—S71
Food Animal
CE Test Correction
: « |
Che answers to CE test questions 3, 8, and 9 from “Oral Tu- Bayer Agriculture Division Animal Health
mors in Dogs and Cats. Part I. Diagnosis and Clinical Signs’ Baytril 100
(CE test #3; September issue) can be found in “Oral Tumors in |
Dogs and Cats. Part II. Prognosis and Treatment” (CE test #3, | Veterinary Learning Systems
October issue). They cannot be answered properly without | Compendium Binders
reading both parts of the article. The Publisher apologizes for | Compendium Reprints
any confusion this inadvertent error may have caused. Infectious Disease in Food Animal Practice
SEPTEMBER 1998 QUIZ ANSWERS
ARTICLE #1 ARTICLE #5
Managing Bite Wounds in Dogs and Cats. Part Il —E. B. Davidson Acquired and Inherited Platelet Dysfunction in Small Animals
4 2. b3.a Gopegui, B. F. Feldman
6. a d 8. b we 2. a 3. « i
6. b 7.48.4
ARTICLE #2
Severe Brain Injury. Part I. Therapy— J. Proulx, N. Dhupa ARTICLE #6
l.d 2.a3.b 4.4 5. ¢ Management of Distal Limb Lameness in Foals— A J. Kaneps, B. L. Smith
6. b 7.a8.b 9. b 10. d l. a ~7¢€¢3 ¢€ 4.a 5. b
ARTICLE # 3 6. b 7 a ‘ d 10. b
Oral Tumors in Dogs and Cats. Part I Diagnosis and Clinical Signs ARTICLE #7
Dhaliwal, B. E. Kitchell, S. M. Marretta Papillomatous Digital Dermatitis: Treatment and Contro! Strategies. Part Il—J. K
2.b3.d & 6 2@ Shearer, J. Hernandez, J. B. Elliott
7e8d 9.410. ¢ » ad 4.d4 1§0. b.
ARTICLE #4
Cervical Spinal Hyperesthesia as a Clinical Sign of Intracranial Disease ARTICLE #8
Coates, C. W. Dewey Replacement Heifer Development: Nutritional Aspects—R. L. Larson
«, ¢ 3.b l. ¢ 2.4d3.b 4 a S.«
ids.e c 6. b 7. 4 9 b10